Search the registry
Find clinical trials
Searching 2,585 mirrored studies from ClinicalTrials.gov.
Create a profile
to see personalised match scores.
2,585 studies found
Recruiting
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Phase 2 · 2 sites
Recruiting
Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML
Phase 2 · 13 sites
Potential match only. Final eligibility is determined by the study team.